Doege–Potter syndrome

Doege–Potter syndrome is a rare medical condition characterized by the presence of a non-islet cell tumor hypoglycemia (NICTH) due to a solitary fibrous tumor (SFT). The syndrome was first described by Karl Doege and Roy P. Potter in 1930.

Symptoms

The main symptom of Doege–Potter syndrome is hypoglycemia, or low blood sugar. This is caused by the production of insulin-like growth factor 2 (IGF-2) by the tumor. Other symptoms can include weight loss, weakness, and fatigue.

Diagnosis

Diagnosis of Doege–Potter syndrome can be challenging due to its rarity. It is typically diagnosed through a combination of clinical findings, laboratory tests, and imaging studies. The diagnosis is confirmed by the presence of a solitary fibrous tumor and hypoglycemia.

Treatment

Treatment for Doege–Potter syndrome typically involves surgical removal of the tumor. In some cases, medication may be used to manage symptoms of hypoglycemia.

Prognosis

The prognosis for Doege–Potter syndrome varies depending on the size and location of the tumor, as well as the patient's overall health. With treatment, some patients may experience a complete resolution of symptoms.

See also

• Non-islet cell tumor hypoglycemia
• Solitary fibrous tumor
• Hypoglycemia

External links

• Doege–Potter syndrome at WikiMD

Doege–Potter syndrome Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski